May 17, 2020

Neovii Pharmaceuticals names its new CEO

Catherine Sturman
2 min
Juergen Pohle
Set to take over the role in January, Juergen Pohle will become Neovii Pharmaceuticals new Chief Executive Officer. He is currently the company’s Chie...

Set to take over the role in January, Juergen Pohle will become Neovii Pharmaceuticals new Chief Executive Officer. He is currently the company’s Chief Commercial Officer.

With a patient-focused mission to develop and market novel life-transforming therapies, Neovii has become a biopharmaceutical company with a global presence, and a leader in improving the outcomes in transplantation medicine and treatment options for haemato-oncological as well as immune disorders.

"Neovii has significantly expanded with increasing performance, paving the way to become a recognized player in transplantation medicine," commented current CEO Alexandre Sudarskis. He will continue to support Neovii as Executive Director and member of Neovii Pharmaceuticals Board.

Becoming Head of Marketing and Sales Consulting for Bayer Healthcare in Germany back in 2002, Pohle rose to become Head of Business Strategy & Intelligence, before moving to Novartis Pharma as Head of Business Development and Licensing, gaining further roles in Switzerland and the Czech Republic at the company.

Related stories

Speaking four languages: English, Germany, French and Italian, Pohle joined Neovii Pharmaceuticals in Switzerland in 2016, and has gained over 15 years’ experience in the pharmaceutical industry.

Most recently, he has led the business for Emerging Growth Markets and Institutional Customers such as UNICEF for Novartis Vaccines and Diagnostics AG in Basel.

Chairman David Fuhrer commented: "Juergen's leadership skills, his long-term proven track record and his many years of international experience in the pharmaceutical industry make him the ideal candidate for the position of CEO.

We are extremely pleased that Juergen has embraced the challenge of further driving the development and growth of Neovii."

Share article

May 6, 2021

On the rise: Jack Nathan Health

virtual consultations
Leila Hawkins
2 min
On the rise: Jack Nathan Health
Jack Nathan Health is opening 153 new clinics and launching a telehealth strategy with Walmart Mexico. We take a look at this rapidly-expanding company...

Canadian healthcare company Jack Nathan Medical Corp has announced a major expansion in Mexico, with the opening of 153 new medical clinics in Walmart stores under the brand name Jack Nathan Health. 

The company say these will be located in areas that would benefit from increased medical services, which will include telemedicine options and family health. 

This is the company's largest expansion since it was founded in 2006, and will give Jack Nathan Health a significant presence as a healthcare provider in Mexico, bringing the company's total clinics to the Central American country to 203. 

Leading healthcare in Canada

Jack Nathan Medical Corp is one of Canada’s largest healthcare networks, providing primary, dental and urgent care. Thanks to its partnership with Walmart Canada, it operates clinics in 76 Walmart stores across the country. 

A key part of the company's strategy is the use of technology to drive patient and practitioner engagement. Its online platform offers e-prescribing, patient scheduling and a virtual consultation service, which was developed quickly to enable access to healthcare professionals during the pandemic, as well as COVID-19 screening. 

In November 2020 the company appointed digital health expert Serge Cinelli as its new Chief Technology Officer, to help roll out Jack Nathan's proprietary technology. Following this, in January this year it acquired Writi, a software firm. 

Revolutionising healthcare with technology

Writi's Virtual Healthcare solution is a cloud-based medication-management platform aimed at elderly care providers, and is available on mobile devices and web platforms. It is used by TELUS Health among others, the health division of one of Canada's largest telecommunications companies. 

The acquisition of Writi formed part of Jack Nathan Health's technology roadmap, which includes bringing hospital-quality care to the home.

As well as trading on the Toronto Venture Stock Exchange, earlier this year Jack Nathan began trading shares on the OTCQB, a leading American market for early stage and developing companies. 

Commenting on the recent expansion throughout Mexico, Chairman and Chief Executive Officer George Barakat said: "Jack Nathan Health, in partnership with Walmart, is now positioning itself to become the largest physician serviced healthcare network in Mexico.

"We believe that we are going to revolutionise healthcare as we embark on this historic growth phase.”

Share article